125.515  2.335 (1.9%)		04-14 13:04
Open: 123.465 High: 126.095 Volume: 229,880		Pre. Close: 123.18 Low: 123.465 Market Cap: 5,548(M)

Short term
Mid term
Targets	6-month :	147.35	1-year :	172.11
Resists	First :	126.16	Second :	147.35
Pivot price	116.62
Supports	First :	111.89	Second :	103.08
MAs	MA(5) :	121.31	MA(20) :	114.22
	MA(100) :	113.64	MA(250) :	118.51
MACD	MACD :	2.9	Signal :	1.8
%K %D	K(14,3) :	93.7	D(3) :	92.1
RSI	RSI(14): 68.2
52-week	High :	137.34	Low :	99.89

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ TFX ] has closed below upper band by 4.7%. Bollinger Bands are 8.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	123.52 - 124.01	124.01 - 124.44
Low:	117.56 - 118.15	118.15 - 118.67
Close:	122.13 - 123.12	123.12 - 123.98

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Tue, 14 Apr 2026
Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Cigna (CI) and BioNTech SE (BNTX) - The Globe and Mail

Tue, 14 Apr 2026
Is It Too Late to Buy Teleflex Inc (TFX) After 4.0% Rally? GF Va - GuruFocus

Tue, 14 Apr 2026
Teleflex says Irenic falsely claimed company was not open for buyout offers - MSN

Tue, 14 Apr 2026
Teleflex Incorporated (NYSE:TFX) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Mon, 13 Apr 2026
TELEFLEX INC ($TFX) Former President and CEO 2025 Pay Revealed - Quiver Quantitative

Sun, 12 Apr 2026
Is Teleflex’s Governance Overhaul And Capital Moves Altering The Investment Case For TFX? - Sahm

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	44 (M)
Shares Float	44 (M)
Held by Insiders	0.3 (%)
Held by Institutions	108.3 (%)
Shares Short	2,290 (K)
Shares Short P.Month	2,440 (K)

EPS	1.3
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	70.69
Profit Margin	-45.5 %
Operating Margin	40.5 %
Return on Assets (ttm)	2.5 %
Return on Equity (ttm)	1.5 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	25.33
Sales Per Share	45.02
EBITDA (p.s.)	10.61
Qtrly Earnings Growth	0 %
Operating Cash Flow	341 (M)
Levered Free Cash Flow	13 (M)

PE Ratio	95.96
PEG Ratio	0
Price to Book value	1.77
Price to Sales	2.79
Price to Cash Flow	16.31

Dividend	0.34
Forward Dividend	0
Dividend Yield	0.2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.